Thromb Haemost 1985; 53(02): 249-251
DOI: 10.1055/s-0038-1661286
Original Article
Schattauer GmbH Stuttgart

Defibrination During Warfarin Therapy in a Man with Protein C Deficiency

Robert B Francis Jr.
The Division of Hematology, Dept, of Medicine, Los Angeles Country-University of Southern California Medical Center, Los Angeles, CA, USA
,
William G McGehee
The Division of Hematology, Dept, of Medicine, Los Angeles Country-University of Southern California Medical Center, Los Angeles, CA, USA
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 29. November 1984

Accepted 03. Februar 1985

Publikationsdatum:
18. Juli 2018 (online)

Preview

Summary

A 57 year old man presented with apparently spontaneous lower extremity deep vein thrombosis and pulmonary embolism. He was treated in conventional fashion with intravenous heparin and oral warfarin. After 4 daily doses of warfarin the prothrombin and proconvertin (P+P) time was within therapeutic range, and heparin was stopped. Over the next six hours complete defibrination occurred, associated with severe bleeding complications. Functional protein C measured after normalization of routine coagulation tests averaged 40% of normal, and was only 3.5% of normal immediately prior to the episode of defibrination. We conclude that the very low functional protein C levels seen immediately prior to defibrination were caused by a combination of pre-existent protein C deficiency and warfarin therapy, and directly predisposed to defibrination once heparin was stopped, despite “therapeutic” warfarin anticoagulation. Exacerbation of intravascular coagulation should be considered a potential prothrombotic effect of warfarin therapy in protein C deficient individuals.